-
1
-
-
0342980324
-
Dopamine- And serotonin-receptors in schizophrenia: Results of imaging-studies and implications for pharmacotherapy in schizophrenia
-
Kasper S, Tauscher J, Küfferle B, et al. Dopamine- and serotonin-receptors in schizophrenia: Results of imaging-studies and implications for pharmacotherapy in schizophrenia. Eur Arch Psychiatry Clin Neurosci 1999;249(Suppl 4):IV83-9.
-
(1999)
Eur Arch Psychiatry Clin Neurosci
, vol.249
, Issue.SUPPL. 4
-
-
Kasper, S.1
Tauscher, J.2
Küfferle, B.3
-
2
-
-
0030795988
-
Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
-
Arvanitis LA, Miller BG, the Seroquel Trial 13 study group. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-46.
-
(1997)
Biol Psychiatry
, vol.42
, pp. 233-246
-
-
Arvanitis, L.A.1
Miller, B.G.2
-
3
-
-
0033974433
-
A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, "Seroquel") and haloperidol in schizophrenia
-
Copolov DL, Link CGG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, "Seroquel") and haloperidol in schizophrenia. Psychol Med 2000;30:95-105.
-
(2000)
Psychol Med
, vol.30
, pp. 95-105
-
-
Copolov, D.L.1
Link, C.G.G.2
Kowalcyk, B.3
-
4
-
-
0035036143
-
Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
-
Purdon SE, Malla A, Labelle A, et al. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 2001; 26:137-49.
-
(2001)
J Psychiatry Neurosci
, vol.26
, pp. 137-149
-
-
Purdon, S.E.1
Malla, A.2
Labelle, A.3
-
5
-
-
0030920294
-
Quetiapine in patients with schizophrenia. A high- And low-dose double-blind comparison with placebo
-
Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997; 54:549-57.
-
(1997)
Arch Gen Psychiatry
, vol.54
, pp. 549-557
-
-
Small, J.G.1
Hirsch, S.R.2
Arvanitis, L.A.3
-
6
-
-
0033815652
-
Long-term use of quetiapine in elderly patients with psychotic disorders
-
Tariot PN, Salzman C, Yeung PP, et al. Long-term use of quetiapine in elderly patients with psychotic disorders. Clin Ther 2000;22:1068-84.
-
(2000)
Clin Ther
, vol.22
, pp. 1068-1084
-
-
Tariot, P.N.1
Salzman, C.2
Yeung, P.P.3
-
7
-
-
0034075361
-
A comparison of the effects of quetiapine ("Seroquel") and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment
-
Emsley RA, Raniwalla J, Bailey PJ, et al. A comparison of the effects of quetiapine ("Seroquel") and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. Int Clin Psychopharmacol 2000;15:121-31.
-
(2000)
Int Clin Psychopharmacol
, vol.15
, pp. 121-131
-
-
Emsley, R.A.1
Raniwalla, J.2
Bailey, P.J.3
-
8
-
-
0036735166
-
Optimal dosing of atypical antipsychotics in adults: A review of the current evidence
-
Citrome L, Volavka J. Optimal dosing of atypical antipsychotics in adults: a review of the current evidence. Harv Rev Psychiatry 2002;10:280-91.
-
(2002)
Harv Rev Psychiatry
, vol.10
, pp. 280-291
-
-
Citrome, L.1
Volavka, J.2
-
9
-
-
0037365993
-
Comparative effectiveness of antipsychotic drugs
-
Meibach RC. Comparative effectiveness of antipsychotic drugs. Am J Psychiatry 2003;160:589-90.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 589-590
-
-
Meibach, R.C.1
-
10
-
-
2542433665
-
Experience with atypical antipsychotics in an acute inpatient unit
-
Colorado Springs, CO, USA, 29 March-2 April
-
Keks N, Tonso M, Tabone K, et al. Experience with atypical antipsychotics in an acute inpatient unit. International Congress on Schizophrenia Research, Colorado Springs, CO, USA, 29 March-2 April 2003.
-
(2003)
International Congress on Schizophrenia Research
-
-
Keks, N.1
Tonso, M.2
Tabone, K.3
-
11
-
-
0036854302
-
High degree of tolerability for monotherapy with high doses of quetiapine: A case report
-
Bobes J, Garcia-Portilla MP, Saiz PA, et al. High degree of tolerability for monotherapy with high doses of quetiapine: A case report. J Clin Psychiatry 2002;63:1048-9.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 1048-1049
-
-
Bobes, J.1
Garcia-Portilla, M.P.2
Saiz, P.A.3
-
12
-
-
13544257990
-
High dose quetiapine in treatment refactory schizophrenia
-
Pierre JM, Wirshing DA, Cannell J, et al. High dose quetiapine in treatment refactory schizophrenia. Schizophr Res 2003;60(Suppl 1):299.
-
(2003)
Schizophr Res
, vol.60
, Issue.SUPPL. 1
, pp. 299
-
-
Pierre, J.M.1
Wirshing, D.A.2
Cannell, J.3
-
13
-
-
0036190196
-
Dosing and switching strategies for quetiapine fumarate
-
Cutler AJ, Goldstein JM, Tumas JA. Dosing and switching strategies for quetiapine fumarate. Clin Ther 2002;24:209-22.
-
(2002)
Clin Ther
, vol.24
, pp. 209-222
-
-
Cutler, A.J.1
Goldstein, J.M.2
Tumas, J.A.3
-
14
-
-
0035205669
-
A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) study
-
Mullen J, Jibson MD, Sweitzer D, et al. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) study. Clin Ther 2001;23:1839-54.
-
(2001)
Clin Ther
, vol.23
, pp. 1839-1854
-
-
Mullen, J.1
Jibson, M.D.2
Sweitzer, D.3
-
15
-
-
0037266310
-
Fatalities associated with therapeutic use and overdose of atypical antipsychotics
-
Trenton A, Currier G, Zwemer F. Fatalities associated with therapeutic use and overdose of atypical antipsychotics. CNS Drugs 2003;17:307-24.
-
(2003)
CNS Drugs
, vol.17
, pp. 307-324
-
-
Trenton, A.1
Currier, G.2
Zwemer, F.3
-
16
-
-
0042424762
-
Seizures associated with quetiapine treatment
-
Dogu O, Sevim S, Kaleagasi HS. Seizures associated with quetiapine treatment. Ann Pharmacother 2003;37: 1224-7.
-
(2003)
Ann Pharmacother
, vol.37
, pp. 1224-1227
-
-
Dogu, O.1
Sevim, S.2
Kaleagasi, H.S.3
-
18
-
-
0024996068
-
Advanced Alzheimer's disease is a risk factor for late-onset seizures
-
Romanelli MF, Morris JC, Ashkin K, et al. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;47:847-50.
-
(1990)
Arch Neurol
, vol.47
, pp. 847-850
-
-
Romanelli, M.F.1
Morris, J.C.2
Ashkin, K.3
-
19
-
-
0036843053
-
Elevation of carbamazepine-10, 11-epoxide by quetiapine
-
Fitzgerald BJ, Okos AJ. Elevation of carbamazepine-10, 11-epoxide by quetiapine. Pharmacotherapy 2002;22: 1500-3.
-
(2002)
Pharmacotherapy
, vol.22
, pp. 1500-1503
-
-
Fitzgerald, B.J.1
Okos, A.J.2
-
21
-
-
0034807482
-
Agranulocytosis and granulocytopenia associated with quetiapine
-
Ruhe HG, Becker HE, Jessurun P, et al. Agranulocytosis and granulocytopenia associated with quetiapine. Acta Psychiatr Scand 2001;104:311-3.
-
(2001)
Acta Psychiatr Scand
, vol.104
, pp. 311-313
-
-
Ruhe, H.G.1
Becker, H.E.2
Jessurun, P.3
|